Cargando…
Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic
In this period of global pandemic caused by SARS-Cov-2, it is of paramount importance to recognize all risk factors that may increase the likelihood of infection. In addition to the risk factors known as pre-existing diseases and old age, risk factors could be drug treatments for chronic diseases, s...
Autores principales: | Ferrara, Francesco, Santilli, Priscilla, D'Aiuto, Vilma, Vitiello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421614/ https://www.ncbi.nlm.nih.gov/pubmed/34513612 http://dx.doi.org/10.34172/apb.2021.045 |
Ejemplares similares
-
Logistics management provides greater efficiency, governance and compliance
por: Ferrara, Francesco, et al.
Publicado: (2021) -
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
por: Ferrara, Francesco, et al.
Publicado: (2020) -
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020) -
Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade
por: Vitiello, A., et al.
Publicado: (2021)